In addition, Nyman et al.[38] used FOXP1 and MUM1/IRF4 as activated B-cell-like markers to distinguish patients between the activated B-cell-like and other diffuse large B-cell lymphoma subtypes. The gene discussed is FOXP1; the disease is diffuse large B-cell lymphoma.